Unknown

Dataset Information

0

An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.


ABSTRACT: The human CD30 receptor is highly overexpressed on the surface of Hodgkin Reed-Sternberg cells and has been shown to be an excellent target for selective immunotherapy using monoclonal antibody-based agents such as immunotoxins. To construct a new recombinant immunotoxin for possible clinical use in patients with Hodgkin's lymphoma, we have chosen the murine anti-CD30 hybridoma Ki-4 to generate a high-affinity Ki-4 single-chain variable fragment (scFv). Hybridoma V-genes were polymerase chain reaction-amplified, assembled, cloned and expressed as a mini-library for display on filamentous phage. Functional Ki-4 scFv were obtained by selection of binding phage on the Hodgkin lymphoma-derived, CD30-expressing cell line L540Cy. The selected recombinant Ki-4 scFv was shown to specifically bind to an overlapping epitope on the CD30 antigen with binding kinetics similar to those of the original antibody. The Ki-4 scFv was subsequently fused to a deletion mutant of Pseudomonas exotoxin A (ETA'). The resulting immunotoxin Ki-4(scFv)-ETA' specifically binds to CD30+ L540Cy cells and inhibits the protein synthesis by 50% at a concentration (IC50) of 43 pM. This recombinant immunotoxin is a promising candidate for further clinical evaluation in patients with Hodgkin's lymphoma or other CD30+ malignancies.

SUBMITTER: Klimka A 

PROVIDER: S-EPMC2362362 | biostudies-other | 1999 Jun

REPOSITORIES: biostudies-other

altmetric image

Publications

An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.

Klimka A A   Barth S S   Matthey B B   Roovers R C RC   Lemke H H   Hansen H H   Arends J W JW   Diehl V V   Hoogenboom H R HR   Engert A A  

British journal of cancer 19990601 8


The human CD30 receptor is highly overexpressed on the surface of Hodgkin Reed-Sternberg cells and has been shown to be an excellent target for selective immunotherapy using monoclonal antibody-based agents such as immunotoxins. To construct a new recombinant immunotoxin for possible clinical use in patients with Hodgkin's lymphoma, we have chosen the murine anti-CD30 hybridoma Ki-4 to generate a high-affinity Ki-4 single-chain variable fragment (scFv). Hybridoma V-genes were polymerase chain re  ...[more]

Similar Datasets

| S-EPMC4080209 | biostudies-literature
| S-EPMC7102329 | biostudies-literature
| S-EPMC7394282 | biostudies-literature
| S-EPMC45374 | biostudies-other
| S-EPMC18478 | biostudies-literature
| S-EPMC7136452 | biostudies-literature
| S-EPMC5042201 | biostudies-literature
| S-EPMC7655020 | biostudies-literature
| S-EPMC5849188 | biostudies-literature
| S-EPMC5058698 | biostudies-literature